Picture of Chimerix logo

CMRX — Chimerix News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Chimerix Inc reports results for the quarter ended in December - Earnings Summary

* Chimerix Inc  CMRX.OQ  reported a quarterly adjusted loss
of 24
cents​​ per share for the quarter ended in December. The mean
expectation of six analysts for the quarter was for a loss of 24
cents per share.
    * Revenue rose 1,669.6% to $814.00 thousand from a year ago;
analysts expected $483.50 thousand. 
    * Chimerix Inc's reported EPS for the quarter was a loss
of 24
cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Chimerix Inc shares had fallen by 14.5% this quarter.
    * The company reported a quarterly loss of $20.96 million.
    * Wall Street's median 12-month price target for Chimerix
Inc is
$6.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data March 2
at 02:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.24          -0.24          Met
 Sep. 30 2022      2.14           2.75           Beat
 Jun. 30 2022      -0.24          -0.27          Missed
 Mar. 31 2022      -0.33          -0.28          Beat

Recent news on Chimerix

See all news